April 22 (Reuters) - Bristol Myers Squibb and Cellares said on Monday they have reached a $380 million deal to supply CAR-T cell therapies to more patients.
(Reporting by Christy Santhosh; Editing by Shinjini Ganguli)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.01 USD | -0.23% | -2.07% | -14.23% |
May. 16 | Everlasting momentum | |
May. 16 | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
April 22 (Reuters) - Bristol Myers Squibb and Cellares said on Monday they have reached a $380 million deal to supply CAR-T cell therapies to more patients.
(Reporting by Christy Santhosh; Editing by Shinjini Ganguli)
1st Jan change | Capi. | |
---|---|---|
-14.23% | 89.42B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |